Ann Lucas
Family Medicine · Platteville, WINPI 1750305629
Payments from drug & device makers
Across 227 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Boehringer Ingelheim$409
- AstraZeneca$309
- Pfizer$278
- Dexcom, Inc.$235
- Lilly USA, LLC$220
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,988100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 57 | $1,018 |
| Boehringer Ingelheim | 19 | $409 |
| AstraZeneca | 19 | $309 |
| Pfizer | 15 | $278 |
| Dexcom, Inc. | 10 | $235 |
| Lilly USA, LLC | 15 | $220 |
| Astellas Pharma US Inc | 11 | $171 |
| Novartis | 12 | $160 |
| Amgen | 6 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $101 |
| Merck | 5 | $94 |
| Sage Therapeutics, LLC | 5 | $90 |
| Johnson & Johnson | 6 | $81 |
| E.r. Squibb & Sons, L.L.C. | 5 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Lundbeck LLC | 3 | $61 |
| Amarin Pharma, Inc. | 3 | $54 |
| GE HealthCare | 3 | $53 |
| Neurelis, Inc. | 1 | $40 |
| Sanofi Pasteur Inc. | 2 | $39 |
| Novo Nordisk | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Exact Sciences | 2 | $31 |
| Alkermes, Inc. | 2 | $31 |
| GSK | 2 | $30 |
| Organon | 2 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Bayer | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
How this compares
$3,999 in reported general payments places this provider in the 90th percentile of 1,482 family medicine providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 31 | $39,797 |
| MyrbetriqMirabegron | 36 | $32,848 |
| SynjardyEmpagliflozin/Metformin Hcl | 27 | $32,503 |
| EliquisApixaban | 21 | $23,357 |
| JardianceEmpagliflozin | 12 | $22,378 |
| OzempicSemaglutide | 17 | $18,065 |
| Breo ElliptaFluticasone/Vilanterol | 29 | $16,991 |
| XareltoRivaroxaban | 22 | $13,436 |
| FarxigaDapagliflozin Propanediol | 11 | $13,391 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 12 | $8,725 |
| TrulancePlecanatide | 12 | $6,653 |
| Repatha SureclickEvolocumab | 12 | $6,628 |
| Spiriva RespimatTiotropium Bromide | 13 | $6,560 |
| TradjentaLinagliptin | 12 | $6,342 |
| Atorvastatin Calcium | 316 | $3,770 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimSynjardy, Jardiance, Combivent Respimat, Spiriva Respimat, Tradjenta | $409 | $76,50776 claims |
| Lilly USA, LLCTrulicity | $220 | $39,79731 claims |
| Astellas Pharma US IncMyrbetriq | $171 | $32,84836 claims |
| PfizerEliquis | $278 | $23,35721 claims |
| Novo NordiskOzempic | $39 | $18,06517 claims |
| GSKBreo Ellipta | $30 | $16,99129 claims |
| Johnson & JohnsonXarelto | $81 | $13,43622 claims |
| AstraZenecaFarxiga | $309 | $13,39111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,482 family medicine providers in Wisconsin.
Other family medicine in Platteville
- Kevin CarrPlatteville$9K
- Andrew KlannPlatteville$8K
- Taha El-ShahatMadison$15.6M
- Jonathan MeimanMadison$4.3M
- John AgaibyKenosha$4M
- John LaabsShawano$3.6M
- Jennifer ParsleyElk Mound$1.4M
- William PalinMilwaukee$693K
- Jonathan TemteMadison$542K
- Ryan AndrewsStevens Point$429K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.